Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
2,295
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Dipeptide-modified nanoparticles to facilitate oral docetaxel delivery: new insights into PepT1-mediated targeting strategy

Yuqian DuDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Chutong TianDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Menglin WangDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Di HuangDepartment of Clinical Pharmacology, School of Pharmacy, Dalian Medical University, Dalian, P.R. China; View further author information
,
Wei WeiDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Yan LiuDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Lin LiDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Bingjun SunDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Longfa KouDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Qiming KanSchool of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, P.R. ChinaView further author information
,
Kexin LiuDepartment of Clinical Pharmacology, School of Pharmacy, Dalian Medical University, Dalian, P.R. China; View further author information
,
Cong LuoDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; View further author information
,
Jin SunDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; Correspondence[email protected]
View further author information
&
Zhonggui HeDepartment of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, P.R. China; Correspondence[email protected]
View further author information
 show all
Pages 1403-1413 | Received 13 Apr 2018, Accepted 21 May 2018, Published online: 12 Jun 2018

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Haisheng Peng, Jiahe Wang, Jiayu Chen, Yanbo Peng, Xiaoxian Wang, Ying Chen, David L. Kaplan & Qun Wang. (2023) Challenges and opportunities in delivering oral peptides and proteins. Expert Opinion on Drug Delivery 20:10, pages 1349-1369.
Read now
Yunchun Zhao, Shuya Ye, Yao Zhu, Yue Chen, Shan Yang, Fengmei Wang, Rong Wang, Dongxu Qin, Dongli Sun & Caihong Zheng. (2023) Advancement in transporter-oriented nanoplatforms for cancer therapy. Journal of Drug Targeting 31:5, pages 456-470.
Read now
Longfa Kou, Huirong Huang, Xinlu Lin, Xinyu Jiang, Yi Wang, Qiuhua Luo, Jin Sun, Qing Yao, Vadivel Ganapathy & Ruijie Chen. (2020) Endocytosis of ATB0,+(SLC6A14)-targeted liposomes for drug delivery and its therapeutic application for pancreatic cancer. Expert Opinion on Drug Delivery 17:3, pages 395-405.
Read now
Enhui Zhang, Ronge Xing, Song Liu & Pengcheng Li. (2019) Current advances in development of new docetaxel formulations. Expert Opinion on Drug Delivery 16:3, pages 301-312.
Read now
Yu Xia, Jiayu Zhong, Mingqi Zhao, Ying Tang, Ning Han, Liang Hua, Tiantian Xu, Changbing Wang & Bing Zhu. (2019) Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Drug Delivery 26:1, pages 1-11.
Read now

Articles from other publishers (22)

Jun Ni, Yue Shang, Wen-die Wang, Chen Wang, Ai-min Wang, Gao-jie Li & Shu-zhen Chen. (2023) FASN Inhibitors Enhance Bestatin-Related Tumor Cell Apoptosis Through Upregulating PEPT1. Current Molecular Pharmacology 16:7.
Crossref
Yining Luo, Jingchun Gao, Xukai Jiang, Ling Zhu, Qi Tony Zhou, Michael Murray, Jian Li & Fanfan Zhou. (2023) Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs). Pharmaceutics 15:10, pages 2517.
Crossref
Ömür Acet, Dzmitry Shcharbin, Victoriya Zhogla, Pavel Kirsanov, Inessa Halets-Bui, Burcu Önal Acet, Tuba Gök, Maria Bryszewska & Mehmet Odabaşı. (2023) Dipeptide nanostructures: Synthesis, interactions, advantages and biomedical applications. Colloids and Surfaces B: Biointerfaces 222, pages 113031.
Crossref
Gergely Gyimesi & Matthias A. Hediger. (2023) Transporter-Mediated Drug Delivery. Molecules 28:3, pages 1151.
Crossref
Elena Puris, Gert Fricker & Mikko Gynther. (2023) The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics 15:2, pages 364.
Crossref
Ruijie Chen, Xinlu Lin, Qian Wang, Xingsi An, Xinyu Zhao, Yujie Lin, Tuyue Sun, Chenyang Yan, Aimin Cai, Weilan Cao, Youting Zhang, Qing Yao & Longfa Kou. (2023) Dual-targeting celecoxib nanoparticles protect intestinal epithelium and regulate macrophage polarization for ulcerative colitis treatment. Chemical Engineering Journal 452, pages 139445.
Crossref
Mengran Guo, Zhongshan He, Zhaohui Jin, Lingjing Huang, Jingmei Yuan, Shugang Qin, Xinchun Wang, Lili Cao & Xiangrong Song. (2022) Oral nanoparticles containing naringenin suppress atherosclerotic progression by targeting delivery to plaque macrophages. Nano Research 16:1, pages 925-937.
Crossref
Yaqi Zhang, Yaying Wang, Xiang Li, Di Nie, Chang Liu & Yong Gan. (2022) Ligand-modified nanocarriers for oral drug delivery: Challenges, rational design, and applications. Journal of Controlled Release 352, pages 813-832.
Crossref
Yao Chen, Tongyao Zhao, Meiyu Bai, Tianrui Gu, Jin Sun, Zhonggui He, Shenwu Zhang & Cong Luo. (2022) Emerging small molecule-engineered hybrid nanomedicines for cancer therapy. Chemical Engineering Journal 435, pages 135160.
Crossref
Ludivine Delon, Rachel J. Gibson, Clive A Prestidge & Benjamin Thierry. (2022) Mechanisms of uptake and transport of particulate formulations in the small intestine. Journal of Controlled Release 343, pages 584-599.
Crossref
Rudra Pangeni, Soim Kang, Saurav Kumar Jha, Laxman Subedi & Jin Woo Park. (2021) Intestinal membrane transporter-mediated approaches to improve oral drug delivery. Journal of Pharmaceutical Investigation 51:2, pages 137-158.
Crossref
Bala K. Prabhala, Moazur Rahman, Hussam H. Nour-eldin, Flemming Steen Jørgensen & Osman Mirza. 2021. 219 240 .
Qing Yao, Ruijie Chen, Vadivel Ganapathy & Longfa Kou. (2020) Therapeutic application and construction of bilirubin incorporated nanoparticles. Journal of Controlled Release 328, pages 407-424.
Crossref
Longfa Kou, Qing Yao, Hailin Zhang, Maoping Chu, Yangzom D. Bhutia, Ruijie Chen & Vadivel Ganapathy. (2020) Transporter-Targeted Nano-Sized Vehicles for Enhanced and Site-Specific Drug Delivery. Cancers 12:10, pages 2837.
Crossref
Yining Xu, Neha Shrestha, Véronique Préat & Ana Beloqui. (2020) Overcoming the intestinal barrier: A look into targeting approaches for improved oral drug delivery systems. Journal of Controlled Release 322, pages 486-508.
Crossref
Gang Wang, Lichun Zhao, Qikun jiang, Yixin Sun, Dongyang Zhao, Mengchi Sun, Zhonggui He, Jin sun & Yang Wang. (2020) Intestinal OCTN2- and MCT1-targeted drug delivery to improve oral bioavailability. Asian Journal of Pharmaceutical Sciences 15:2, pages 158-172.
Crossref
Ling Zhang, Chengguang Sui, Wenhan Yang & Qiuhua Luo. (2020) Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy. Asian Journal of Pharmaceutical Sciences 15:2, pages 192-206.
Crossref
Timothy P. Brown & Vadivel Ganapathy. (2020) Lactate/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacology & Therapeutics 206, pages 107451.
Crossref
Zhenjie Wang, Dongxu Chi, Xingchen Wu, Yingli Wang, Xinxin Lin, Zhaochu Xu, Hongzhuo Liu, Jin Sun, Zhonggui He & Yongjun Wang. (2019) Tyrosine modified irinotecan-loaded liposomes capable of simultaneously targeting LAT1 and ATB0,+ for efficient tumor therapy. Journal of Controlled Release 316, pages 22-33.
Crossref
Yixin Sun, Dongyang Zhao, Gang Wang, Qikun Jiang, Mengran Guo, Qiming Kan, Zhonggui He & Jin Sun. (2019) A novel oral prodrug-targeting transporter MCT 1: 5-fluorouracil-dicarboxylate monoester conjugates. Asian Journal of Pharmaceutical Sciences 14:6, pages 631-639.
Crossref
Hongyan Su, Yan Wang, Shuo Liu, Yue Wang, Qian Liu, Guangxuan Liu & Qin Chen. (2019) Emerging transporter-targeted nanoparticulate drug delivery systems. Acta Pharmaceutica Sinica B 9:1, pages 49-58.
Crossref
Daichi Fujita & Ikumi Tamai. (2018) Oral drug delivery system targeting intestinal transporters消化管トランスポーター基質を利用した経口DDSの現状と今後の展開. Drug Delivery System 33:5, pages 377-389.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.